Maged S. Mahmoud

416 total citations
14 papers, 368 citations indexed

About

Maged S. Mahmoud is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Maged S. Mahmoud has authored 14 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Maged S. Mahmoud's work include Multiple Myeloma Research and Treatments (9 papers), Chemokine receptors and signaling (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Maged S. Mahmoud is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Chemokine receptors and signaling (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Maged S. Mahmoud collaborates with scholars based in Japan and Egypt. Maged S. Mahmoud's co-authors include Michio Kawano, Hideaki Ishikawa, Takako Tsujimoto, Atsushi Kuramoto, N Huang, Igor Lisukov, Hideki Asaoku, Yuka Harada, Saeid Abroun and Ken‐ichiro Otsuyama and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and British Journal of Haematology.

In The Last Decade

Maged S. Mahmoud

14 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maged S. Mahmoud Japan 10 200 160 134 130 55 14 368
Kai Herrmann Germany 8 145 0.7× 293 1.8× 213 1.6× 79 0.6× 41 0.7× 8 538
Catherine Spier United States 8 169 0.8× 109 0.7× 150 1.1× 168 1.3× 57 1.0× 10 384
Curtis Je Canada 9 220 1.1× 167 1.0× 78 0.6× 88 0.7× 19 0.3× 12 388
Chantal Doyen Belgium 11 253 1.3× 152 0.9× 241 1.8× 109 0.8× 26 0.5× 21 476
K Naganuma Japan 6 132 0.7× 74 0.5× 200 1.5× 84 0.6× 16 0.3× 13 362
Tina Nuebling Germany 9 106 0.5× 132 0.8× 270 2.0× 247 1.9× 22 0.4× 13 455
G. García-Manero United States 8 139 0.7× 111 0.7× 104 0.8× 64 0.5× 23 0.4× 24 329
Junichiro Yuda Japan 10 180 0.9× 198 1.2× 289 2.2× 268 2.1× 19 0.3× 43 566
Vojkan Susulic United States 3 94 0.5× 54 0.3× 100 0.7× 87 0.7× 14 0.3× 3 271
Chisako Iriyama Japan 10 56 0.3× 154 1.0× 106 0.8× 81 0.6× 92 1.7× 17 329

Countries citing papers authored by Maged S. Mahmoud

Since Specialization
Citations

This map shows the geographic impact of Maged S. Mahmoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maged S. Mahmoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maged S. Mahmoud more than expected).

Fields of papers citing papers by Maged S. Mahmoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maged S. Mahmoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maged S. Mahmoud. The network helps show where Maged S. Mahmoud may publish in the future.

Co-authorship network of co-authors of Maged S. Mahmoud

This figure shows the co-authorship network connecting the top 25 collaborators of Maged S. Mahmoud. A scholar is included among the top collaborators of Maged S. Mahmoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maged S. Mahmoud. Maged S. Mahmoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Shamsasenjan, Karim, Ken‐ichiro Otsuyama, Saeid Abroun, et al.. (2009). IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells. International Journal of Hematology. 89(3). 310–318. 13 indexed citations
2.
Iqbal, Mohd S., Ken‐ichiro Otsuyama, Karim Shamsasenjan, et al.. (2009). Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow. European Journal Of Haematology. 83(4). 302–312. 11 indexed citations
3.
Mahmoud, Maged S., et al.. (2004). Serum IL-2 and platelet-associated immunoglobulins are good prognostic markers in immune thrombocytopenic purpura.. PubMed. 11(2). 121–32. 6 indexed citations
4.
Ishikawa, Hideaki, Naohiro Tsuyama, Maged S. Mahmoud, et al.. (2002). CD19 Expression and Growth Inhibition of Tumours in Human Multiple Myeloma. Leukemia & lymphoma. 43(3). 613–616. 21 indexed citations
5.
Ishikawa, Hideaki, et al.. (2000). Proliferation of Immature Myeloma Cells by Interleukin-6 Is Associated with CD45 Expression in Human Multiple Myeloma. Leukemia & lymphoma. 39(1-2). 51–55. 24 indexed citations
6.
Mahmoud, Maged S., et al.. (1999). Enforced CD19 Expression Leads to Growth Inhibition and Reduced Tumorigenicity. Blood. 94(10). 3551–3558. 39 indexed citations
7.
Ishikawa, Hideaki, et al.. (1999). MPC‐1−CD49e− immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL‐6 in human myelomas. British Journal of Haematology. 105(1). 131–140. 48 indexed citations
8.
Ishikawa, Hideaki, et al.. (1999). MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas. British Journal of Haematology. 105(1). 131–140. 1 indexed citations
9.
Mahmoud, Maged S., et al.. (1998). Induction of CD45 Expression and Proliferation in U-266 Myeloma Cell Line by Interleukin-6. Blood. 92(10). 3887–3897. 59 indexed citations
10.
Mahmoud, Maged S., et al.. (1998). Induction of CD45 Expression and Proliferation in U-266 Myeloma Cell Line by Interleukin-6. Blood. 92(10). 3887–3897. 4 indexed citations
11.
Kawano, Michio, Maged S. Mahmoud, & Hideaki Ishikawa. (1997). Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively. British Journal of Haematology. 99(1). 131–138. 23 indexed citations
12.
Harada, Yuka, Michio Kawano, N Huang, et al.. (1996). Identification of early plasma cells in peripheral blood and their clinical significance. British Journal of Haematology. 92(1). 184–191. 93 indexed citations
13.
Mahmoud, Maged S. & Michio Kawano. (1996). Cloning and Analysis of the Human Pax-5 Gene Promoter. Biochemical and Biophysical Research Communications. 228(1). 159–164. 9 indexed citations
14.
Kawano, Michio, Maged S. Mahmoud, N Huang, et al.. (1995). High proportions of VLA‐5− immature myeloma cells correlated well with poor response to treatment in multiple myeloma. British Journal of Haematology. 91(4). 860–864. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Herrmann Breakdown of academic impact, for papers by Catherine Spier Breakdown of academic impact, for papers by Curtis Je Breakdown of academic impact, for papers by Chantal Doyen Breakdown of academic impact, for papers by K Naganuma Breakdown of academic impact, for papers by Tina Nuebling Breakdown of academic impact, for papers by G. García-Manero Breakdown of academic impact, for papers by Junichiro Yuda Breakdown of academic impact, for papers by Vojkan Susulic Breakdown of academic impact, for papers by Chisako Iriyama
Rankless by CCL
2026